| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |